The utility of predicting intrapartum fetal compromise at term using fetal cerebro-umbilical ratio and maternal placental growth factor

Not Applicable

Recruiting

• Conditions: fetal compromise; Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy

• Registration Number: ACTRN12616001009404
• Lead Sponsor: Mater Health Services

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-08-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 500

Inclusion Criteria

Singleton pregnancy, with cephalic presentation, planning a vaginal birth.

Exclusion Criteria

Multiple pregnancy, maternal BMI>40, known fetal anomaly or growth restriction, previous caesarean section, known rupture of membranes, pathological umbilical artery dopplers.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Composite outcome of: <br>- emergency caesarean section for fetal compromise, or <br>- severe adverse neonatal outcomes (cord arterial pH <7.1 and/or Lactate >6 mmol.L or base excess >12 or Apgar score <5 at 5 minutes), or<br>- fetal/neonatal death. [Within 28 days of delivery of baby as this encompasses the entire neonatal period. ]